DKC clients include the largest segment of health care providers in New York City, some of the most prestigious medical institutions in the country, individual physicians and their practices as well as organizations such as the Children’s Health Fund, one of the nation’s largest health care pediatric programs. As a result, we understand health care from two viewpoints—that of the provider and that of the media.

Given our broad client base, we have developed exceptionally close relationships with local and national health reporters. With information available to us from numerous hospitals and physicians, the media knows that we spot the trends that make the news. We are experts in the media’s eyes, worthy of their trust.

DKC seeks to elevate our clients to that same expert status with the media. For example, in our work promoting fundraising efforts for the construction of Montefiore Medical Center’s Children’s Hospital at Montefiore, we established the hospital’s president, Dr. Irwin Redlener, as a leading voice in children’s health care issues. DKC was integral in positioning Beth Israel Medical Center’s Institute for Neurology and Neurosurgery as the premier center for ailments and injuries affecting the brain and spinal cord. To promote New York University Medical Center’s Department of Neuro-Oncology, we highlighted the groundbreaking work of its director, Dr. Michael Gruber, establishing him as a leader and pioneer in treating brain tumors.

In the aftermath of the September 11th tragedy, DKC established Saint Vincent Catholic Medical Centers as the region’s premier expert in emergency medicine, nuclear, biologic and chemical disaster preparedness.

DKC received an Ace Award from the International Association of Business Communicators for our New York Daily News Prostate Cancer Screening Program. For this effort, DKC teamed Continuum Health Partners and Saint Vincent Catholic Medical Centers of New York (a combined total of 13 hospitals) with the New York Daily News to create the largest free prostate screening program ever undertaken in the New York metropolitan area. The program tested 26,000 men in six days of which 10% were found to have elevated PSA levels. This past summer marked the third annual screening program.